194 related articles for article (PubMed ID: 27853930)
21. Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy.
Eisen D; Essell J; Broun ER; Sigmund D; DeVoe M
Bone Marrow Transplant; 2003 Jan; 31(1):51-5. PubMed ID: 12621507
[TBL] [Abstract][Full Text] [Related]
22. Pediatric herpes simplex of the anterior segment: characteristics, treatment, and outcomes.
Liu S; Pavan-Langston D; Colby KA
Ophthalmology; 2012 Oct; 119(10):2003-8. PubMed ID: 22796308
[TBL] [Abstract][Full Text] [Related]
23. A new promising candidate to overcome drug resistant herpes simplex virus infections.
Zinser E; Krawczyk A; Mühl-Zürbes P; Aufderhorst U; Draßner C; Stich L; Zaja M; Strobl S; Steinkasserer A; Heilingloh CS
Antiviral Res; 2018 Jan; 149():202-210. PubMed ID: 29155164
[TBL] [Abstract][Full Text] [Related]
24. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
Zuckerman RA; Lucchetti A; Whittington WL; Sanchez J; Coombs RW; Zuñiga R; Magaret AS; Wald A; Corey L; Celum C
J Infect Dis; 2007 Nov; 196(10):1500-8. PubMed ID: 18008230
[TBL] [Abstract][Full Text] [Related]
25. Current practice and knowledge of oral care for cancer patients: a survey of supportive health care providers.
Barker GJ; Epstein JB; Williams KB; Gorsky M; Raber-Durlacher JE
Support Care Cancer; 2005 Jan; 13(1):32-41. PubMed ID: 15549427
[TBL] [Abstract][Full Text] [Related]
26. Assessment trials of the therapeutic efficacy of the drug "Zovirax" in some recurrent ocular and genital herpetic infections.
Muţiu A; Sahnazarov N; Crişan I
Rom J Virol; 1998; 49(1-4):27-42. PubMed ID: 10892424
[TBL] [Abstract][Full Text] [Related]
27. Perineal herpes simplex infection in bedridden geriatric patients.
Nikkels AF; Piérard GE
Am J Clin Dermatol; 2007; 8(2):79-83. PubMed ID: 17428112
[TBL] [Abstract][Full Text] [Related]
28. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
Fife KH; Warren TJ; Justus SE; Heitman CK;
Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
[TBL] [Abstract][Full Text] [Related]
29. Oral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management.
Arduino PG; Porter SR
Oral Dis; 2006 May; 12(3):254-70. PubMed ID: 16700734
[TBL] [Abstract][Full Text] [Related]
30. Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret's.
Tyler KL
Herpes; 2004 Jun; 11 Suppl 2():57A-64A. PubMed ID: 15319091
[TBL] [Abstract][Full Text] [Related]
31. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.
Tyring SK; Baker D; Snowden W
J Infect Dis; 2002 Oct; 186 Suppl 1():S40-6. PubMed ID: 12353186
[TBL] [Abstract][Full Text] [Related]
32. Development of the MASCC/ISOO Clinical Practice Guidelines for Mucositis: considerations underlying the process.
Elad S; Bowen J; Zadik Y; Lalla RV;
Support Care Cancer; 2013 Jan; 21(1):309-12. PubMed ID: 23064884
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of valacyclovir vs acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study.
Miserocchi E; Modorati G; Galli L; Rama P
Am J Ophthalmol; 2007 Oct; 144(4):547-51. PubMed ID: 17692271
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic interventions for herpes simplex virus epithelial keratitis.
Wilhelmus KR
Cochrane Database Syst Rev; 2007 Jan; (1):CD002898. PubMed ID: 17253484
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic interventions for herpes simplex virus epithelial keratitis.
Wilhelmus KR
Cochrane Database Syst Rev; 2008 Jan; (1):CD002898. PubMed ID: 18254009
[TBL] [Abstract][Full Text] [Related]
36. Topical and systemic therapies for oral and perioral herpes simplex virus infections.
Stoopler ET; Balasubramaniam R
J Calif Dent Assoc; 2013 Apr; 41(4):259-62. PubMed ID: 23705241
[TBL] [Abstract][Full Text] [Related]
37. Herpes Mastitis: Diagnosis and Management.
Toussaint A; Simonson C; Valla C
Breast J; 2016 May; 22(3):335-8. PubMed ID: 26899615
[TBL] [Abstract][Full Text] [Related]
38. Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis.
Pechère M; Wunderli W; Trellu-Toutous L; Harms M; Saura JH; Krischer J
Dermatology; 1998; 197(3):278-80. PubMed ID: 9812037
[TBL] [Abstract][Full Text] [Related]
39. Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection.
Seang S; Boutolleau D; Burrel S; Regnier S; Epelboin L; Voujon D; Valantin MA; Katlama C; Agut H; Caumes E
Int J STD AIDS; 2014 Aug; 25(9):676-82. PubMed ID: 24535691
[TBL] [Abstract][Full Text] [Related]
40. Recurrent herpetic keratitis despite antiviral prophylaxis: A virological and pharmacological study.
Rousseau A; Boutolleau D; Titier K; Bourcier T; Chiquet C; Weber M; Colin J; Gueudry J; M'Garrech M; Bodaghi B; Burrel S; Agut H; Deback C; ; Labetoulle M
Antiviral Res; 2017 Oct; 146():205-212. PubMed ID: 28939476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
